NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS   RESOURCES  
Small Claims Guide   Class Actions   Lemon Laws   FAQ   Newsletters  
Share


Complain about a product or service

Automotive    Education    Employment    Electronics    Family    Finance    Health    Homeowners    Insurance    Pets    Shopping    Travel     Print This     Email This    



NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Weight-Loss Products Illegally Spiked with Prescription Drugs

Public Citizen: FDA response 'inadequate'





April 30, 2009
At least 72 weight-loss products have been found by the Food and Drug Administration (FDA) to contain prescription drugs, including four drugs not approved by the FDA for sale in the U.S., according to Public Citizen's WorstPills.org

This is the third time in the past six months that the FDA has announced alerts about the illegal addition of active prescription drug ingredients to otherwise ineffective weight-loss supplements.

Because the added drugs are active in the body, they can be dangerous as well. For instance, sibutramine (brand name Meridia, an appetite suppressant available by prescription only and a controlled substance) and fluoxetine (brand names Prozac and Serafem, an antidepressant available by prescription only) were among the drugs found in the supplements.

The FDA has inspected a number of companies associated with the sale of these illegal products and is currently seeking voluntary recalls of the 72 products.

Based on the FDA's inspections and the companies' responses to recall requests, the FDA may take additional enforcement steps, such as issuing warning letters or initiating seizures, injunctions or criminal charges.

"The FDA's response has been inadequate," said Sidney M. Wolfe, M.D., director of Public Citizen's Health Research Group and acting Public Citizen president. "Some of the drugs found in these supplements are dangerous and are putting people at an unacceptable risk of injury. To protect citizens, the agency needs to go further and seize these products."

The affected weight-loss products are categorized as dietary supplements by the FDA.

Due to the 1994 Dietary Supplement Health and Education Act (DSHEA), which clarified that dietary supplements were to be regulated essentially as foods rather than as drugs, dietary supplements are not subject to the better-controlled process for approval and manufacturing as drugs.

Thus, the manufacturers of dietary supplements are not required to submit proof that their products are safe and effective, or that the amount of a substance claimed to be in a supplement is actually in the supplement, or that contaminants or active drugs are not present.

Moreover, on the rare occasions on which dietary supplements have been subjected to the same rigorous, controlled trials as drugs, the majority of supplements have been found to be ineffective.

Dietary supplement manufacturers sometimes seek to gain a competitive advantage by clandestinely adding prescription drugs to a largely inactive dietary supplement.

Unfortunately for the companies, this has the side effect of converting these products from dietary supple*ments into prescription drugs. To sell prescription drugs without FDA approval is illegal, providing the basis for the FDA's possible actions.

"Most dietary supplements do not fall under the jurisdiction of the FDA, but this is one case where all of these products are clearly in violation of the laws that govern drugs," Wolfe said. "The FDA has not exercised its legal authority to seize all of these products and take them off the market, and anything short of that simply is not good enough."

WorstPills.org includes the full list of 72 implicated weight-loss products, as well as the nine drugs they may contain.

These include, in addition to Meridia and Prozac/Serafem, fenproporex (a stimulant drug not approved for marketing in the U.S.); bumetanide (brand name Bumex, a potent diuretic available by prescription only); furosemide (brand name Lasix, a potent diuretic available by prescription only); rimonabant (brand name Zimulti, an appetite supp ressant not approved for marketing in the U.S.); cetilistat (an experimental obesity drug not approved for marketing in the U.S.); phenytoin (brand name Dilantin, an anti-seizure medication available by prescription only); and phenolphthalein (a solution used in chemical experiments and a suspected cancer-causing agent that is not approved for marketing in the United States).

Some of the affected weight-loss products include Slimtech, 2 Day Diet and Miaozi Slim Capsules. A full list of these products is available on WorstPills.org.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Share

Follow us on Twitter.

FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!





CONSUMER NEWS

SAFETY RECALLS

Back to the top |

Advertisement


Custom Search
AUTOMOTIVE
• Dealers
• Manufacturers
• Service
• Extended Warranties
• Lemon Laws
• Recalls
• Tires
• Transporters

FAMILY
• Aging
• Children, Parenting
• Recalls
• Dating
• Education
• Entertainment
• Pets
• Weddings
FINANCE
• Annuities
• Banks
• Credit Cards
• Debt Collection
• Debt Counseling
• Insurance
• Investing
• Loans
• Mortgages
• Payday Loans
• Student Loans
• Tax Prep

HEALTH
• Doctors
• Drugs, Pharmacies
• Health Clubs
• Hearing Care
• Hospitals
• Nursing Homes
• Nutrition, Diets
• Vision Care
• Weight Loss
HOUSE & HOME
• Appliances
• Cookware
• Furniture
• Home Improvements
• Lawn & Garden
• Movers
• Pools & Spas
• Realtors, Rental Agents
• Recalls
• Utilities

ELECTRONICS
• Cable TV/DBS
• Cameras
• Cell Phones
• Computers
• Home Electronics
• Internet Access
• Local Phone Service
• Long Distance
• VoIP
SHOPPING
• In-Home
• Online
• Retail Stores
• Sporting Goods
• Supermarkets
• Telemarketers

TRAVEL
• Airlines
• Bus Lines
• Car Rental
• Cruises
• Hotels
• Travel Agents
• Trains

RESOURCES
• Class Actions
• Complaint Form
• Small Claims Guide
• Lemon Laws
CONSUMER NEWS
• Latest News
• Automotive
• Telecom
• Financial
• Health
• Homeowners
• Scams
• Seniors
• Travel
• More ...

RECALLS
• Automotive
• Children's Products
• Drugs
• Food
• Household Products
• Sporting Goods

ABOUT US
• FAQ
• Privacy Policy
• Advertise With Us
• Newsroom
• Syndication
• Terms of Use

Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2009 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.